Thursday, 5 March, 2026
Sebi approves PharmEasy's Rs 6,250 crore IPO
By Basit Ansari
<p>The parent company of PharmEasy, API Holdings, has received approval from India's securities regulator, SEBI, for the online pharmacy's IPO. API Holdings filed draught IPO papers in November in order to raise Rs 6,250 cr through the sale of primary shares. Existing shareholders have no plans to sell their stock. Sebi's approval for PharmEasy parent's IPO comes at a time when new-age companies' share values have been steadily declining since going public last year.</p>
Read full story at The Economic Times
Tags: